Literature DB >> 21909223

Isolated epidermolytic acanthoma in a renal transplant recipient.

Ji-Hye Yang1, Jae-Kyung Kim, Chong-Hyun Won, Sung-Eun Chang, Mi-Woo Lee, Jee-Ho Choi, Kee-Chan Moon.   

Abstract

Entities:  

Year:  2011        PMID： 21909223      PMCID： PMC3162282          DOI： 10.5021/ad.2011.23.3.415

Source DB:  PubMed          Journal:  Ann Dermatol        ISSN： 1013-9087            Impact factor:   1.444


× No keyword cloud information.
  6 in total

1.  Epidermolytic acanthoma does not contain human papillomavirus DNA.

Authors:  C Leonardi; W Zhu; W Kinsey; N S Penneys
Journal:  J Cutan Pathol       Date:  1991-04       Impact factor: 1.587

2.  Epidermolytic acanthomas: clinical characteristics and immunohistochemical features.

Authors:  P R Cohen; R Ulmer; A Theriault; I M Leigh; M Duvic
Journal:  Am J Dermatopathol       Date:  1997-06       Impact factor: 1.533

3.  Disseminated epidermolytic acanthoma revealed by PUVA.

Authors:  T Nakagawa; M Nishimoto; T Takaiwa
Journal:  Dermatologica       Date:  1986

4.  Isolated epidermolytic acanthoma. A solitary tumor showing granular degeneration.

Authors:  L Shapiro; C S Baraf
Journal:  Arch Dermatol       Date:  1970-02

5.  Histopathologic concept of epidermolytic hyperkeratosis.

Authors:  A B Ackerman
Journal:  Arch Dermatol       Date:  1970-09

6.  Disseminated epidermolytic acanthoma with disseminated superficial porokeratosis and verruca vulgaris in an immunosuppressed patient.

Authors:  S I Chun; J S Lee; N S Kim; K D Park
Journal:  J Dermatol       Date:  1995-09       Impact factor: 4.005
  6 in total
  2 in total

1.  Presentation of epidermolytic acanthomas as multiple tan papules on the vulva.

Authors:  J Wesley Fletcher; Arathi Ramamurthi; Palak Parekh
Journal:  Proc (Bayl Univ Med Cent)       Date:  2016-04

2.  Two Cases of Multiple Epidermolytic Acanthomas Mimicking Verruca Vulgaris.

Authors:  Hyun Jeong Byun; Donghwi Jang; Jongeun Lee; Se Jin Oh; Ji-Hye Park; Dong-Youn Lee
Journal:  Ann Dermatol       Date:  2020-11-11       Impact factor: 1.444
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.